Tonix Pharmaceuticals Holding Corp.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $13.1 | $10.1 | $7.8 | — | — |
| Operating income | -$125.7 | -$136.7 | -$118.4 | -$112.1 | -$92.3 |
| Net income | -$124.0 | -$130.0 | -$116.7 | -$110.2 | -$92.3 |
| Balance Sheet | |||||
| Total debt | — | $5.8 | $8.7 | — | — |
| Cash Flow Statement | |||||
| Free cash flow | -$103.2 | -$61.0 | -$109.9 | -$146.2 | -$110.9 |
| Share repurchases | $13.8 | — | $14.0 | — | — |
Shares outstanding 17.2M · Free float 94.5%
Annual filing data through FY ended December 31, 2025; float as of September 29, 2026.